Bangkece Shanghai Intelligent Medical Technology
Develops venipuncture robots that help in conducting blood collection without human intervention.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 Valuation: €0.0 | round | |
* | N/A | CNY20.0m Valuation: CNY500m | Early VC |
| Total Funding | 000k | ||
Related Content
Bangkece Shanghai Intelligent Medical Technology Co., Ltd., operating as Puncture Robotic, is a medical technology firm established in 2019. The company is focused on addressing the procedural challenges within medical institutions by developing advanced robotic systems. It is headquartered in Shanghai, China, and was formerly known as Pound Kece (Shanghai) Robotics Co., Ltd.
The core of Bangkece's business is the development and manufacturing of venipuncture robots designed to automate blood collection without human intervention. These systems leverage a combination of artificial intelligence, machine learning, and real-time image navigation for precise soft tissue intervention. This technology extends beyond simple blood draws, finding applications in other medical fields requiring percutaneous punctures, such as procedures involving thoracoabdominal and pelvic tumors, as well as medical aesthetics. The firm aims to deliver a suite of automation, informatization, and intelligent solutions to its client base of hospitals and health organizations.
The business model centers on providing these affordable medical robots to healthcare facilities, targeting a market that benefits from increased efficiency and procedural accuracy. The company's intellectual property portfolio includes 59 patents, signaling a strong research and development focus. Bangkece is a privately held, venture capital-backed entity that has successfully secured later-stage VC funding from at least 11 investors, including notable names like Lenovo Capital and Incubator Group (LCIG) and Shenzhen Capital Group, indicating significant investor confidence in its technology and market strategy.
Keywords: venipuncture robots, automated blood collection, medical robotics, intelligent medical solutions, percutaneous puncture, soft tissue intervention, image-guided robotics, healthcare automation, medical aesthetics technology, medtech, AI in healthcare, machine learning in medicine, Puncture Robotic, Pound Kece, thoracoabdominal procedures, pelvic tumor procedures, medical device manufacturing, Shanghai medtech, venture capital-backed, Lenovo Capital, Shenzhen Capital Group